Relapse Analysis and Resistance Mutations of PML-Rara Fusion Gene in Acute Promyelocytic Leukemia Patients Treated with All-Trans Retinoic Acid and Arsenic

被引：0
|
作者：
Chen, Jiaqi [1 ,2 ,3 ]
Liu, Hongxing [1 ,3 ,4 ]
Wang, Fang [3 ,5 ]
Chen, Xue [1 ]
Zhang, Yang [1 ,3 ]
Cao, Panxiang [5 ]
Ma, Xiaoli [5 ]
Li, Yu [1 ]
机构：
[1] Hebei Yanda Lu Daopei Hosp, Div Lab Med, Langfang, Peoples R China
[2] Beijing Lu Daopei Hosp, Beijing, Peoples R China
[3] Beijing Lu Daopei Inst Hematol, Beijing, Peoples R China
[4] Beijing Lu Daopei Hosp, Div Lab Med, Beijing, Peoples R China
[5] Hebei Yanda Lu Daopei Hosp, Div Pathol & Lab Med, Langfang, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149404
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2243
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Pharmacokinetics of all-trans retinoic acid in acute promyelocytic leukemia patients on dialysis
    Takitani, K
    Nagai, K
    Kanbe, E
    Inoue, A
    Kawakami, C
    Kuno, T
    Tamai, H
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 74 (02) : 147 - 148
  • [42] PHARMACOKINETICS OF ORAL ALL-TRANS RETINOIC ACID IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
    LEFEBVRE, P
    THOMAS, G
    GOURMEL, B
    AGADIR, A
    CASTAIGNE, S
    DREUX, C
    DEGOS, L
    CHOMIENNE, C
    LEUKEMIA, 1991, 5 (12) : 1054 - 1058
  • [43] Pulmonary embolism in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid
    JimenezYuste, V
    Martin, MP
    Canales, M
    Ojeda, E
    HernandezNavarro, F
    LEUKEMIA, 1997, 11 (11) : 1988 - 1989
  • [44] Distinctive features associated with differentiation syndrome in acute promyelocytic leukemia in patients treated by all-trans retinoic acid and arsenic trioxide
    Cingelova, Silvia
    Mikuskova, Eva
    Demitrovicova, Ludmila
    Mikudova, Vanda
    Slobodova, Alica
    Spanikova, Jana
    Vasickova, Radka
    Urban, Denis
    Drgona, Lubos
    Oravcova, Iveta
    LEUKEMIA RESEARCH, 2024, 145
  • [45] Efficacy of all-trans retinoic acid for molecular relapse of acute promyelocytic leukemia during remission
    Tamura, S
    Takemoto, Y
    Takami, S
    Kinoshita, M
    Kumano, Y
    Aono, H
    Mori, M
    Kakishita, E
    ONCOLOGY REPORTS, 1999, 6 (03) : 683 - 685
  • [46] TREATMENT OF 1ST RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA WITH ALL-TRANS RETINOIC ACID
    DEGOS, L
    CHOMIENNE, C
    DANIEL, MT
    BERGER, R
    DOMBRET, H
    FENAUX, P
    CASTAIGNE, S
    LANCET, 1990, 336 (8728): : 1440 - 1441
  • [47] The Role of Quantitation of PML-RARa Fusion Transcript in the Risk Stratification in Patients with Acute Promyelocytic Leukemia
    Cho, Y.
    Chi, H.
    Park, S.
    Jang, S.
    Park, C.
    Seo, E.
    Lee, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 662 - 662
  • [48] Oral arsenic and all-trans retinoic acid for high-risk acute promyelocytic leukemia
    Zhu, Hong-Hu
    Liu, Yan-Rong
    Jia, Jin-Song
    Qin, Ya-Zhen
    Zhao, Xiao-Su
    Lai, Yue-Yun
    BLOOD, 2018, 131 (26) : 2987 - 2989
  • [49] Arsenic and all-trans retinoic acid for acute promyelocytic leukemia: yes, it really is as good as it seems
    Levis, Mark
    HAEMATOLOGICA, 2021, 106 (12) : 3031 - 3032
  • [50] Central nervous system relapse in acute promyelocytic leukaemia treated with all-trans retinoic acid
    Seldon, M
    Enno, A
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (04): : 462 - 462
12345